LSM-Med announced this month the accrediting of the Anvisa Certificate for Lipo-Med in Brazil, marking a crucial step towards commercialization. The Lipo-Med System is used in harvesting autologous adipose tissue.
Autologous adipose tissue, rich in mesenchymal stem cells, holds promising clinical applications in orthopaedic surgery, arthroscopic surgery, wound healing, plastics, and reconstructive surgery. The Lipo-Med System is provided as a single-use sterile product.
This achievement highlights LSM-Med’s dedication to delivering innovative healthcare solutions and expanding its global presence. With the certification in hand, LSM-Med is poised to introduce Lipo-Med to the Brazilian market, aiming to enhance healthcare outcomes and patient well-being globally.
